Enterprise

Inspiren Raises $70M Series C for AI Fall Prevention in Senior Living

The New York startup uses ambient sensors and computer vision to alert caregivers before residents fall, now serving over 500 communities.

Omega Editorial· September 13, 2026· 3 min read

Inspiren Raises $70M Series C for AI Fall Prevention in Senior Living

Inspiren, a New York-based startup building AI-powered safety technology for senior living facilities, has closed a $70 million Series C funding round led by NewView Capital. The investment brings the company's total capital raised to $225 million and values it at more than $500 million, according to details first reported by MedCity News.

The company's core product addresses a persistent challenge in senior care: preventing falls before they occur. Inspiren deploys proprietary hardware called AUGi (augmented intelligence) that mounts on apartment walls and uses computer vision combined with ambient sensors to detect movement patterns that typically precede falls — such as unsteady walking or rising from a chair — then alerts caregivers in real time.

Why it matters

Falls represent one of the costliest and most dangerous events in senior living, often triggering hospitalization, injury, and rapid decline. Traditional monitoring relies on cameras streaming to the cloud or post-incident alerts, creating delays that reduce effectiveness. Inspiren's approach processes data on-device, eliminating lag and privacy concerns while shifting the intervention window from reactive to predictive. With more than 500 communities already using the platform, the company is demonstrating that ambient AI can scale across fragmented senior care markets.

From bedside nurse to AI founder

Chief Clinical Officer Michael Wang, who founded Inspiren in 2016, drew on his experience as both a Green Beret and a geriatrics and cardiothoracic surgical nurse. He described the core problem driving the company's creation: caregivers can only protect one resident at a time, and only when physically present.

"As soon as I walk out of that door, it's anyone's guess on the safety and well-being of that particular person," Wang said.

Unlike conventional camera-based systems, Inspiren manufactures its own hardware rather than relying on off-the-shelf components, giving the company tighter control over data capture and processing. All analysis happens on the device itself, not in the cloud, which eliminates streaming delays and reduces privacy exposure.

Wang emphasized that hardware alone doesn't differentiate the company. Inspiren maintains a large clinical team that conducts weekly or biweekly consultations with communities, helping staff interpret data and optimize workflows. That clinical support is embedded in the company's sales model.

Expansion beyond fall prevention

With the new capital, Inspiren plans to expand its go-to-market team, broaden its hardware ecosystem, and train its AI models to detect and predict a wider range of resident needs. The company is also building out capabilities beyond fall prevention, including staff optimization tools and a recently launched AI-powered emergency call system.

Inspiren currently serves more than 500 senior living communities across the United States.

Details of the funding round were first reported by MedCity News.

#senior living#fall prevention#ambient ai#computer vision#healthcare sensors#series c funding

This is an original analysis by the Omega editorial team. Source reporting: AI Watch.

Want systems like this working for your business?

Book a Call

More in Enterprise

Enterprise· 4 min read

Dr. Martens Rebuilt Customer Service From Scratch After Years of Decline

The footwear brand consolidated fragmented systems across regions onto Salesforce and AWS, reversing a three-year slide in customer satisfaction within months.

Via Automation Watch · Sep 24, 2026
Enterprise· 4 min read

AI Coding Tools Added $942M to Hospital Bills Without Care Changes

Blue Cross Blue Shield Association analysis finds hospitals using automation to classify more cases as complex, driving up costs with no documented increase in treatment intensity.

Via AI Watch · Sep 24, 2026
Enterprise· 4 min read

AI Clinical Trial Endpoints Fail at Scale Without Data Harmonization

Analysis of over one million patient screenings reveals that AI validation in single sites masks critical performance drift across multi-site deployments.

Via AI Watch · Sep 24, 2026